Cargando…

Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study

INTRODUCTION: To investigate the efficacy and safety of trelagliptin 25 mg in patients with type 2 diabetes mellitus with severe renal impairment or end‐stage renal disease. MATERIALS AND METHODS: This multicenter, randomized, phase 3 study comprised a 12‐week double‐blind phase followed by a 40‐wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaku, Kohei, Ishida, Kazuyuki, Shimizu, Kohei, Achira, Meguru, Umeda, Yuusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078116/ https://www.ncbi.nlm.nih.gov/pubmed/31389201 http://dx.doi.org/10.1111/jdi.13126

Ejemplares similares

Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study
por: Kaku, Kohei, et al.
Publicado: (2018)

Efficacy and safety of once‐weekly oral trelagliptin switched from once‐daily dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: An open‐label, phase 3 exploratory study
por: Inagaki, Nobuya, et al.
Publicado: (2017)

Long‐term safety and efficacy of a novel once‐weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52‐week open‐label, phase 3 study
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Combined Cardiac Impairments in End-Stage Renal Disease
por: Sobieszczańska, Małgorzata, et al.
Publicado: (2012)

Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes
por: Tosaki, Takahiro, et al.
Publicado: (2017)

Safety and efficacy of vemurafenib in end stage renal failure
por: Iddawela, Mahesh, et al.
Publicado: (2013)

Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome
por: Ryosaka, Makoto, et al.
Publicado: (2013)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
por: Kudo, Masatoshi, et al.
Publicado: (2021)

Cognitive impairment and microvascular function in end‐stage renal disease
por: Angermann, Susanne, et al.
Publicado: (2022)

Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial
por: Kaku, Kohei, et al.
Publicado: (2019)

Suitability of various chromatographic and spectroscopic techniques for analysis and kinetic degradation study of trelagliptin
por: Zaghary, Wafaa A., et al.
Publicado: (2017)

Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product
por: Mowaka, Shereen, et al.
Publicado: (2018)

A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis
por: Gupta, Neeraj, et al.
Publicado: (2016)

Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population
por: Mowaka, Shereen, et al.
Publicado: (2021)

Living‐donor kidney transplantation in an end‐stage renal disease patient with situs inversus totalis: Three case reports
por: Ochi, Atsuhiko, et al.
Publicado: (2019)

Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
por: Kato, Manabu, et al.
Publicado: (2017)

Randomized, double‐blind, phase III study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes
por: Kaku, Kohei, et al.
Publicado: (2017)

Safety, efficacy, and early clinical experience of insulin degludec in Japanese people with diabetes mellitus: A first-year report from Japan
por: Kaku, Kohei, et al.
Publicado: (2015)

Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol
por: Ishii, Hitoshi, et al.
Publicado: (2017)

Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients
por: Tanaka, Tomotaka, et al.
Publicado: (2021)

Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study
por: Kaku, Kohei, et al.
Publicado: (2020)

Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease
por: Rogula, Sylwester, et al.
Publicado: (2022)

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes
por: Hirukawa, Hidenori, et al.
Publicado: (2018)

Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment
por: Sulkowski, Mark, et al.
Publicado: (2022)

Reduced White Matter Integrity With Cognitive Impairments in End Stage Renal Disease
por: Yin, Yi, et al.
Publicado: (2018)

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
por: Lønning, Kjersti, et al.
Publicado: (2016)

Primary Renal Lymphoma Presenting as End-Stage Renal Disease
por: Butani, Lavjay, et al.
Publicado: (2017)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
por: Ruchi, Rupam, et al.
Publicado: (2019)

Safety and Tolerability of Remdesivir in Patients with End-stage Renal Disease on Maintenance Hemodialysis
por: Shah, Maulin K, et al.
Publicado: (2022)

Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of a phase 3 randomized clinical trial
por: Kaneko, Shizuka, et al.
Publicado: (2018)

Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo‐controlled trial
por: Kaku, Kohei, et al.
Publicado: (2019)

End-Stage Renal Disease and Renal Replacement Therapy in older Patients
por: Smyth, Andrew
Publicado: (2012)

Renal replacement therapy in Latin American end-stage renal disease
por: Rosa-Diez, Guillermo, et al.
Publicado: (2014)

Letter to the editor: spontaneous renal haemorrhage in end-stage renal disease
por: Tonolini, Massimo, et al.
Publicado: (2015)

Abnormal brain functional networks in end‐stage renal disease patients with cognitive impairment
por: Yue, Zheng, et al.
Publicado: (2021)

Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective study
por: Katsuma, Ai, et al.
Publicado: (2018)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

A Randomized Pilot Study of the Effect of Trelagliptin and Alogliptin on Glycemic Variability in Patients with Type 2 Diabetes
por: Nishimura, Rimei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5120f67osmocnt0rkghmbum2n7